A GLANCE ON GSK HISTORYIn 1880, Burroughs Wellcome & Company was founded in London by American pharmacists Henry Wellcome and Silas Burroughs. Glaxo was founded in Bunnythorpe, New Zealand in 1904. Originally Glaxo was a baby food manufacturer processing local milk into a baby food by the same name: the product was sold in the 1930s under the slogan "glaxo builds bonny babies".

In 1830, John K. Smith opened its first pharmacy in Philadelphia. In 1865 mahlonKline joined the business which, 10 years later, became Smith, Kline & Co.

In 2000, glaxo welcome and SmithKline Beecham merged to form GlaxoSmithKline.

GSK IN PAKISTANGlaxoSmithKline Pakistan Limited was created on January 1st 2002 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan (Private) Limited and Glaxo Wellcome (Pakistan) Limited- standing today as the largest pharmaceutical company in Pakistan.

and GSK PAKISTAN MISSION STATEMENT“Our mission is to improve the quality of human life by enabling people to do more, feel better live longer.”

GSK AREA OF BUSINESS

GSK Pakistan operates mainly in two industry segments: Pharmaceuticals (prescription drugs and vaccines) and consumer healthcare (over-the-counter- medicines, oral care and nutritional care).

GSK INTERNAL VIEW

GSK BALANCE SHEET VIEW FOR FIRST QUARTER OF 2010:

Total Current Assets 25,106,856

Total Fixed Assets 29,583,065Total Assets 66,117,643Total Liabilities 52,203,660Total Equity 13,913,982Total Liabilities & Stock Equity 66,117,643

GSK PAKISTAN LEADING PRODUCTPHARMACEUTICAL PRODUCT

PANADOL EXTRA

AUGMINTEN

GSK HEALTH CARE PRODUCT

Macleans

MACLEANS SENSITIVE

HORLICKS

SWOT ANALYSIS OF GSK PAKISTAN

Strengths

 [*]Strong management team [*]Reputation management [*]sound capital base [*]good infrastructure [*]large market share [*]large highly skilled work force

Weaknesses

 [*]Low market dominance  [*]low online presence  [*]Inconsistency of attractive promotions  [*]High dependancy on only several products

Opportunities  [*]Emerging markets and expansion abroad  [*]Developing vaccines for persistent diseases

Threats

 [*]Lower cost competitors or imports [*]counterfeit drugs being sold in competition with legitimate products

A GLANCE ON ABBOTT LABORTRIES HISTORY

Abbott Laboratories has its origin in the late 19th century in a small pharmaceutical operation run from the kitchen of a Chicago physician named Wallace Calvin Abbott. As did other physicians of the time, Dr. Abbott commonly prescribed morphine, quinine, strychnine, and codeine--all of which were liquid alkaloid extracts--for his patients. Because they existed only in a liquid form, these

drugs were prone to spoilage over timemitigating their effectiveness as treatment.

ABBOTT LABORTRIES OF PAKISTAN SHORT HISTORY

Abbott Pakistan is part of the global healthcare corporation of Abbott Laboratories, Chicago, USA.Abbott started operations in Pakistan as a marketing affiliate in 1948; the company has steadily expanded to comprise a work force of over 1500 employees. Currently two manufacturing facilities located at Landhi and Korangi in Karachi continue to use innovative technology to produce top quality pharmaceutical products.Abbott Pakistan has leadership in the field of Pain Management, Anesthesia, Medical Nutrition and Anti-Infectives.

MISSION STATEMENT AND VISION

Vision

“To be a premier healthcare

company in Pakistan”

Mission

“To deliver consistently superior

products and services which

contribute significantly to improvethe quality of life of the

consumers.”

ABBOTT PAKISTAN INTERNAL VIEW

Market ShareAbbott Pakistan achieved a market share of 6.1% as per IMS (Dec 2010, 12

Months) in the pharmaceutical and nutrition market (2009 market share: 5.8%).

ABBOTT PAKISTAN BALANCE SHEET VIEW FOR 2010ALL THE AMOUN IN RS:

Fixed Assets - property, plant

and equipment: 1,877,596

Other Non-Current Assets: 56,152

Current Assets: 3,856,673

Total Assets: 5790421

Issued, subscribed and paid-up capital: 979,003

Capital Reserves: 197,167

Revenue Reserves: 2,736,369

Total Equity: 3,912,539

Non-Current Liabilities: 115,182

ABBOTT LABORTRIES OF PAKISTAN`s MAIN PRODUCT

Abbott Labortries of Pakistan engaged in the following product catagery.

ABBOTT DIABATIES PRODUCT

Pharmaceutical Products

: brufen sirup

Nutritional Products

NUTRITIONAL PRODUCTS

Swot analysis of abbott labortries

Strengths, Weaknesses, Opportunities and Threats (SWOT)

Location of Factor TYPE OF FACTORFavorable Unfavorable

Internal Strengths

Continued uptake of Humira across autoimmune disorder market

Diverse lipid management portfolio

Blockbuster HIV franchise

Weaknesses

Patent exposure set to weaken prescription pharma portfolio

Narrow launch prospects largely restricted to follow-on medications

External Opportunities

Exciting prospect for lucrative vascular intervention segment in Xience V

Early stage pipeline programs in oncology, CNS

Threats

FTC investigation into generic defence strategies

New biologic launches for autoimmune

and immunology disorder market

COMPARISON ON THE BASIS OF SWOT ANALYSIS